ING Groep N.V. : Good timing to anticipate a continuation of the trend
Entry price | Target | Stop-loss | Potential |
---|
€12.7 |
€13.8 |
€12.2 |
+8.66% |
---|
Shares in ING Groep N.V. do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Summary● According to Refinitiv, the company's ESG score for its industry is good.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company appears to be poorly valued given its net asset value.
● The company is one of the best yield companies with high dividend expectations.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● Over the past four months, analysts' average price target has been revised downwards significantly.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.